{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:16:13Z","timestamp":1783296973267,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Science and Technology Program","award":["2025FN96441088"],"award-info":[{"award-number":["2025FN96441088"]}]},{"name":"Guangxi Natural Science Foundation","award":["No. 2024GXNSFAA010392"],"award-info":[{"award-number":["No. 2024GXNSFAA010392"]}]},{"name":"Natural Science Foundation of Guangxi","award":["2020GXNSFAA159124"],"award-info":[{"award-number":["2020GXNSFAA159124"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-026-02384-9","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T04:03:36Z","timestamp":1778472216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic and proteomic analysis of osteogenesis imperfecta disease-specific induced pluripotent stem cells"],"prefix":"10.1186","volume":"19","author":[{"given":"Ruijun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chune","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianliang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"2384_CR1","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","volume":"3","author":"JC Marini","year":"2017","unstructured":"Marini JC, Forlino A, B\u00e4chinger HP, et al. Osteogenesis imperfecta. Nat Rev Dis Primers. 2017;3:17052.","journal-title":"Nat Rev Dis Primers"},{"issue":"9418","key":"2384_CR2","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363(9418):1377\u201385.","journal-title":"Lancet"},{"issue":"2","key":"2384_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1172\/JCI115622","volume":"89","author":"JR Shapiro","year":"1992","unstructured":"Shapiro JR, Stover ML, Burn VE, et al. An osteopenic nonfracture syndrome with features of mild osteogenesis imperfecta associated with the substitution of a cysteine for glycine at triple helix position 43 in the pro alpha 1(I) chain of type I collagen. J Clin Invest. 1992;89(2):567\u201373.","journal-title":"J Clin Invest"},{"issue":"1","key":"2384_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/bmmb.1993.1001","volume":"49","author":"P Vandenberg","year":"1993","unstructured":"Vandenberg P. Molecular basis of heritable connective tissue disease. Biochem Med Metab Biol. 1993;49(1):1\u201312.","journal-title":"Biochem Med Metab Biol"},{"issue":"7","key":"2384_CR5","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1096\/fasebj.5.7.2010058","volume":"5","author":"H Kuivaniemi","year":"1991","unstructured":"Kuivaniemi H, Tromp G, Prockop DJ. Mutations in collagen genes: causes of rare and some common diseases in humans. Faseb j. 1991;5(7):2052\u201360.","journal-title":"Faseb j"},{"issue":"2","key":"2384_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16(2):101\u201316.","journal-title":"J Med Genet"},{"issue":"14","key":"2384_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339(14):947\u201352.","journal-title":"N Engl J Med"},{"key":"2384_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.matbio.2018.03.010","volume":"71\u201372","author":"R Morello","year":"2018","unstructured":"Morello R. Osteogenesis imperfecta and therapeutics. Matrix Biol. 2018;71\u201372:294\u2013312.","journal-title":"Matrix Biol"},{"issue":"5","key":"2384_CR9","doi-asserted-by":"publisher","first-page":"e10118","DOI":"10.1002\/jbm4.10118","volume":"3","author":"JS Bains","year":"2019","unstructured":"Bains JS, Carter EM, Citron KP, et al. A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta. JBMR Plus. 2019;3(5):e10118.","journal-title":"JBMR Plus"},{"issue":"3","key":"2384_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11914-014-0225-0","volume":"12","author":"A Biggin","year":"2014","unstructured":"Biggin A, Munns CF. Osteogenesis imperfecta: diagnosis and treatment. Curr Osteoporos Rep. 2014;12(3):279\u201388.","journal-title":"Curr Osteoporos Rep"},{"issue":"10","key":"2384_CR11","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1210\/jc.2002-020334","volume":"87","author":"J-J Body","year":"2002","unstructured":"Body J-J, Gaich GA, Scheele WH, et al. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1\u201334)] with alendronate in postmenopausal women with osteoporosis. J Clin Endocrinol Metabolism. 2002;87(10):4528\u201335.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"19","key":"2384_CR12","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434\u201341.","journal-title":"N Engl J Med"},{"issue":"4","key":"2384_CR13","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663\u201376.","journal-title":"Cell"},{"issue":"5","key":"2384_CR14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861\u201372.","journal-title":"Cell"},{"key":"2384_CR15","doi-asserted-by":"publisher","first-page":"1205122","DOI":"10.3389\/fbioe.2023.1205122","volume":"11","author":"A Fus-Kujawa","year":"2023","unstructured":"Fus-Kujawa A, Mendrek B, Bajdak-Rusinek K, et al. Gene-repaired iPS cells as novel approach for patient with osteogenesis imperfecta. Front Bioeng Biotechnol. 2023;11:1205122.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"2384_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10(1):57\u201363.","journal-title":"Nat Rev Genet"},{"issue":"5","key":"2384_CR17","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrg.2016.10","volume":"17","author":"SA Byron","year":"2016","unstructured":"Byron SA, Van Keuren-Jensen KR, Engelthaler DM, Carpten JD, Craig DW. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet. 2016;17(5):257\u201371.","journal-title":"Nat Rev Genet"},{"key":"2384_CR18","unstructured":"Cummings BB, Marshall JL, Tukiainen T et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med. 2017;9(386)."},{"issue":"6928","key":"2384_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nature01511","volume":"422","author":"R Aebersold","year":"2003","unstructured":"Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422(6928):198\u2013207.","journal-title":"Nature"},{"issue":"3","key":"2384_CR20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","volume":"165","author":"Y Liu","year":"2016","unstructured":"Liu Y, Beyer A, Aebersold R. On the Dependency of Cellular Protein Levels on mRNA Abundance. Cell. 2016;165(3):535\u201350.","journal-title":"Cell"},{"issue":"12","key":"2384_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.31083\/j.fbl2812336","volume":"28","author":"D Li","year":"2023","unstructured":"Li D, Ou M, Dai G, et al. Genotypic Characterization of a Chinese Family with Osteogenesis Imperfecta and Generation of Disease-Specific Induced Pluripotent Stem Cells. Front Biosci (Landmark Ed). 2023;28(12):336.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"2384_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13287-019-1369-8","volume":"10","author":"M Ou","year":"2019","unstructured":"Ou M, Li C, Tang D, et al. Genotyping, generation and proteomic profiling of the first human autosomal dominant osteopetrosis type II-specific induced pluripotent stem cells. Stem Cell Res Ther. 2019;10(1):251.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"2384_CR23","doi-asserted-by":"publisher","first-page":"e16478","DOI":"10.15252\/emmm.202216478","volume":"15","author":"N Nabavizadeh","year":"2023","unstructured":"Nabavizadeh N, Bressin A, Shboul M, et al. A progeroid syndrome caused by a deep intronic variant in TAPT1 is revealed by RNA\/SI-NET sequencing. EMBO Mol Med. 2023;15(2):e16478.","journal-title":"EMBO Mol Med"},{"key":"2384_CR24","doi-asserted-by":"publisher","first-page":"1164386","DOI":"10.3389\/fendo.2023.1164386","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Li G, Wei L, et al. Tibial plateau fracture and RNA sequencing with osteogenesis imperfecta: a case report. Front Endocrinol (Lausanne). 2023;14:1164386.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2384_CR25","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/bcp.13803","volume":"85","author":"FM Hannan","year":"2019","unstructured":"Hannan FM, Newey PJ, Whyte MP, Thakker RV. Genetic approaches to metabolic bone diseases. Br J Clin Pharmacol. 2019;85(6):1147\u201360.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"2384_CR26","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","volume":"97","author":"K Okamoto","year":"2017","unstructured":"Okamoto K, Nakashima T, Shinohara M, et al. Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. Physiol Rev. 2017;97(4):1295\u2013349.","journal-title":"Physiol Rev"},{"issue":"3","key":"2384_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/er.2017-00064","volume":"38","author":"WC Lee","year":"2017","unstructured":"Lee WC, Guntur AR, Long F, Rosen CJ. Energy Metabolism of the Osteoblast: Implications for Osteoporosis. Endocr Rev. 2017;38(3):255\u201366.","journal-title":"Endocr Rev"},{"key":"2384_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.biocel.2016.08.034","volume":"79","author":"S Lemma","year":"2016","unstructured":"Lemma S, Sboarina M, Porporato PE, et al. Energy metabolism in osteoclast formation and activity. Int J Biochem Cell Biol. 2016;79:168\u201380.","journal-title":"Int J Biochem Cell Biol"},{"issue":"7","key":"2384_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41574-024-00969-x","volume":"20","author":"S Stegen","year":"2024","unstructured":"Stegen S, Carmeliet G. Metabolic regulation of skeletal cell fate and function. Nat Rev Endocrinol. 2024;20(7):399\u2013413.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2384_CR30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1530\/JOE-17-0335","volume":"234","author":"I Boraschi-Diaz","year":"2017","unstructured":"Boraschi-Diaz I, Tauer JT, El-Rifai O, et al. Metabolic phenotype in the mouse model of osteogenesis imperfecta. J Endocrinol. 2017;234(3):279\u201389.","journal-title":"J Endocrinol"},{"issue":"3","key":"2384_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1542\/peds.49.3.375","volume":"49","author":"GJ Cropp","year":"1972","unstructured":"Cropp GJ, Myers DN. Physiological evidence of hypermetabolism in osteogenesis imperfecta. Pediatrics. 1972;49(3):375\u201391.","journal-title":"Pediatrics"},{"issue":"7","key":"2384_CR32","doi-asserted-by":"publisher","first-page":"e10753","DOI":"10.1002\/jbm4.10753","volume":"7","author":"CL Omosule","year":"2023","unstructured":"Omosule CL, Joseph D, Weiler B, et al. Whole-Body Metabolism and the Musculoskeletal Impacts of Targeting Activin A and Myostatin in Severe Osteogenesis Imperfecta. JBMR Plus. 2023;7(7):e10753.","journal-title":"JBMR Plus"},{"issue":"2","key":"2384_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41580-022-00531-5","volume":"24","author":"P Kanchanawong","year":"2023","unstructured":"Kanchanawong P, Calderwood DA. Organization, dynamics and mechanoregulation of integrin-mediated cell-ECM adhesions. Nat Rev Mol Cell Biol. 2023;24(2):142\u201361.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2384_CR34","doi-asserted-by":"publisher","first-page":"122542","DOI":"10.1016\/j.biomaterials.2024.122542","volume":"308","author":"EN Holland","year":"2024","unstructured":"Holland EN, Fern\u00e1ndez-Yag\u00fce MA, Zhou DW, et al. FAK, vinculin, and talin control mechanosensitive YAP nuclear localization. Biomaterials. 2024;308:122542.","journal-title":"Biomaterials"},{"issue":"3","key":"2384_CR35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12020-022-03181-x","volume":"78","author":"G Qiao","year":"2022","unstructured":"Qiao G, Xing J, Luo X, Zhang C, Yi J. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome. Endocrine. 2022;78(3):615\u201327.","journal-title":"Endocrine"},{"issue":"10","key":"2384_CR36","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.21873\/anticanres.15311","volume":"41","author":"S Islam","year":"2021","unstructured":"Islam S, Kitagawa T, Azuma T, Kuramitsu Y. The Expression Levels of Vinculin in Pancreatic Cancer Tissues Significantly Correlates With Patient Survival. Anticancer Res. 2021;41(10):4979\u201384.","journal-title":"Anticancer Res"},{"issue":"4","key":"2384_CR37","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.18632\/aging.202440","volume":"13","author":"H Li","year":"2021","unstructured":"Li H, Wang C, Lan L, et al. High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer. Aging. 2021;13(4):5197\u2013225.","journal-title":"Aging"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02384-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02384-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:13:30Z","timestamp":1783296810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02384-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2384"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02384-9","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committee of Shenzhen People\u2019s Hospital. The study\u2019s participants\u2019 written informed consent was obtained from the patients. This study received approval from the Medical Ethics Committee of The Second Affiliated Hospital of Guilin Medical University (Guilin, China), in accordance with the ethical guidelines outlined in the Declaration Helsinki for conducting medical research involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}